/
Occupational Formaldehyde Exposure and Cancer Risk Occupational Formaldehyde Exposure and Cancer Risk

Occupational Formaldehyde Exposure and Cancer Risk - PowerPoint Presentation

danika-pritchard
danika-pritchard . @danika-pritchard
Follow
389 views
Uploaded On 2018-02-05

Occupational Formaldehyde Exposure and Cancer Risk - PPT Presentation

Laura Beane Freeman PhD Occupational and Environmental Epidemiology Branch Division of Cancer Epidemiology and Genetics April 24 2012 Formaldehyde An Important Chemical Ubiquitous in atmosphere and life forms ID: 628256

exposure leukemia trend formaldehyde leukemia exposure formaldehyde trend myeloid funeral evidence nasopharyngeal workers cancer industry peak study high medium

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Occupational Formaldehyde Exposure and C..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Occupational Formaldehyde Exposure and Cancer Risk

Laura Beane Freeman, Ph.D.Occupational and Environmental Epidemiology BranchDivision of Cancer Epidemiology and GeneticsApril 24, 2012Slide2

Formaldehyde: An Important Chemical

Ubiquitous in atmosphere and life forms >5% of yearly U.S. GDP2.1 million U.S. workers exposed (1995)Fixatives and disinfectantsWood products, resins, molded plastics, crease-resistant fabrics, paper productsEnvironmental exposuresOff-gassing from home furnishings, automobile engines, cigarette smoke, incomplete fuel combustionSlide3

Background: Evidence for Carcinogenicity

Genotoxic Causes DNA-protein cross-links at site of contactInhaled formaldehyde causes nasal tumors in rats3Slide4

Carcinogenicity of Formaldehyde

WHO-IARC review in 2004Sufficient evidence for nasopharyngeal cancerStrong, but not sufficient evidence for leukemiaWHO-IARC review in 2009Sufficient evidence for leukemia, particularly myeloidReaffirmed status for nasopharyngeal cancerNational Toxicology Program Report on Carcinogens 2009Sufficient evidence for nasopharyngeal cancer and myeloid leukemiaEPA ongoingUpdating risk assessment of formaldehydeSlide5

U.S. Occupational StandardOSHA:

0.75 ppm for 8-h time weighted average 2.0 ppm for short-term exposure limitSlide6

Formaldehyde Research: 2 Exposure Scenarios

Study of Funeral Industry WorkersNCI Cohort of Industrial WorkersSlide7

Leukemia among Professionals

* 95% CI does not include 1.0Slide8

Study of Funeral Industry WorkersSlide9

Case Control Study of Funeral Industry Workers

6,808 deaths among 13,994 inactive/deceased funeral directors/embalmersIdentified through professional associations and licensing boards (deaths from 1960-86)168 deaths from lymphohematopoietic malignancies 34 from myeloid leukemia265 controls: deaths due to natural causesMatched by study source, sex, dates of birth and deathSlide10

Study of Funeral Industry Workers: Exposure Assessment

1,278 interviews with next of kin and co-workersWork history, including embalming characteristicsPer job: start/end, funeral home, embalming, # embalmings (autopsied/intact), ventilationPer subject: duration of typical embalming, frequency of spillsSmoking historySlide11

Study of Funeral Industry Workers: Exposure Assessment

Exposure study25 embalmings under controlled conditionsVentilationSolution strengthType of case (intact or autopsy)Continuous measurement of formaldehyde concentration in breathing zoneExposure levels:Average intensity while embalming: 1.7 ppm8-hr time weighted average: 0.2 ppmPeak exposure while embalming: 8.6 ppmSlide12

Cancer in the Funeral Industry: Results

Non-lymphoid LHPMOR

Myeloid Leukemia

OR

Duration (y)

<500 embalmings

<

20 years

>20-34 years

>34 years

REF

0.3

2.0

2.6

p-trend=0.046

REF

0.5

3.2

3.9

p-trend=0.020

# of embalmings

<500

>

500-1422

1423-3068

>3068

REF

0.6

1.8

2.3

p-trend=0.247

REF

1.22.93.0p-trend=0.314

Hauptmann, et al., JNCI 2009

Slide13

Cancer in the Funeral Industry: ResultsSimilar results for other metrics:

Myeloid leukemia: Cumulative exposure: p-trend=0.192Average intensity while embalming: p=trend=0.058TWA8 intensity: p-trend=0.396Peak exposure: p-trend=0.036No associations with other LHPMSlide14

NCI Cohort of Industrial WorkersSlide15

NCI Industrial Cohort StudyMortality study of 25,619 workers in 10 plants

Employed prior to 1966Work histories through 1980Time-dependent exposure metrics 13,951 deaths as of 200442 years of median follow-upSlide16

NCI Industrial Cohort: Relative Risks by Peak Formaldehyde Exposure (ppm)

0

>0-<2.0

2.0-<4.0

>

4.0

RR

1.07

0.59

0.27

0.82

RR

1.0

1.0

1.0

1.0

RR

1.17

0.98

0.81

1.30

RR

1.37*

1.42

1.15

1.78

p-trend

0.02

>0.50

>0.50

0.13

Lymphohemato

Leukemia

Lymphatic leukemia

Myeloid leukemia

Beane Freeman, et al., JNCI. 2009; 101: 751-761.

Slide17

17

RR for Medium and High Peak Formaldehyde Exposure Categories

Exposure-response trend p-values

RR for Peak Medium

High

Date of last work history

`

Myeloid LeukemiaSlide18

18

RR for Medium and High Peak Formaldehyde Exposure Categories

RR for Peak

Medium

High

Myeloid Leukemia

Lymphatic LeukemiaSlide19

RR for Medium and High Peak Formaldehyde Exposure Categories and p-values for Trend Tests Among Exposed Person-years

All HLPNHL

Hodgkin Lymphoma

Multiple Myeloma

Leukemia

Lymphatic Leukemia

Myeloid LeukemiaSlide20

RR for Medium and High Average Intensity Formaldehyde Exposure Categories and p-values for Trend Tests Among Exposed Person-years

All HLP

NHL

Hodgkin Lymphoma

Multiple Myeloma

Leukemia

Lymphatic Leukemia

Myeloid LeukemiaSlide21

Nasopharyngeal Cancer 8 exposed cases All cases in highest peak exposure category:

RR=1.83, p-trend=0.044Consistent with case-control studies of nasopharyngeal cancer and animal studiesHauptmann, et al., Amer J Epidemiol, 2004Slide22

Carcinogenicity of Formaldehyde

WHO-IARC review in 2004Sufficient evidence for nasopharyngeal cancerStrong, but not sufficient evidence for leukemiaWHO-IARC review in 2009Sufficient evidence for leukemia, particularly myeloidReaffirmed status for nasopharyngeal cancerNational Toxicology Program Report on Carcinogens 2009Sufficient evidence for nasopharyngeal cancer and myeloid leukemiaEPA ongoingUpdating risk assessment of formaldehydeSlide23